Inhibitor of growth tumor suppressors in cancer progression

Cellular and Molecular Life Sciences

Volumn 67, Issue 12, 2010, Pages 1987-1999

  Piche, Brad ^a   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cancer progression; ING; Invasion; Metastasis; Tumor suppressor

Indexed keywords

ADENYLATE KINASE; COLLAGENASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1; GAG PROTEIN; HISTONE DEACETYLASE 1; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF GROWTH 1; INHIBITOR OF GROWTH 2; INHIBITOR OF GROWTH 3; INHIBITOR OF GROWTH 4; INHIBITOR OF GROWTH 5; INTERLEUKIN 8; LYSINE; MATRIX METALLOPROTEINASE; OSTEOPONTIN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN P33; PROTEIN P47; PROTEIN P53; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL CYCLE REGULATION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME MAP; COLORECTAL CANCER; DNA REPAIR; DNA REPLICATION; GENE LOCUS; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; LEUKEMIA; MELANOMA; METASTASIS POTENTIAL; MOUTH CARCINOMA; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SENESCENCE; SKIN CANCER; SPLICEOSOME; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; DNA REPAIR; GROWTH; GROWTH INHIBITORS; HISTONES; HUMANS; MUTATION; NEOPLASMS; NEOPLASTIC PROCESSES; NF-KAPPA B; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953022035     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0312-z     Document Type: Review

References (96)

1. M Unoki K Kunamoto S Takenoshita CC Harris 2009 Reviewing the current classification of inhibitor of growth family proteins Cancer Sci 100 1173 1179 10.1111/j.1349-7006.2009.01183.x 19432890 1:CAS:528:DC%2BD1MXosl2ktLw%3D
2. D Ythier D Larrieu C Brambilla E Brambilla R Pedeux 2008 The new tumor suppressor genes ING: genomic structure and status in cancer Int J Cancer 123 1483 1490 10.1002/ijc.23790 18636562 1:CAS:528:DC%2BD1cXhtV2ru77O
3. W Gong K Suzuki M Russell K Riabowol 2005 Function of the ING family of PHD proteins in cancer Int J Biochem Cell Biol 37 1054 1065 10.1016/j.biocel. 2004.09.008 15743678 1:CAS:528:DC%2BD2MXhvVCqu74%3D (Pubitemid 40311746)
4. AH Coles SN Jones 2009 The ING gene family in the regulation of cell growth and tumorigenesis J Cell Physiol 218 45 57 10.1002/jcp.21583 18780289 1:CAS:528:DC%2BD1cXhsFahsbbO
5. MA Soliman K Riabowol 2007 After a decade of study-ING, a PHD for a versatile family of proteins Trends Biochem Sci 32 509 519 10.1016/j.tibs.2007. 08.006 17949986 1:CAS:528:DC%2BD2sXht1KktbvN (Pubitemid 350008066)
6. E Campos MY Chine WH Kuo G Li 2004 Biological functions of the ING family tumor suppressors Cell Mol Life Sci 61 2597 2613 10.1007/s00018-004-4199-4 15526165 1:CAS:528:DC%2BD2cXhtVOmt7bO (Pubitemid 39586520)
7. D Larrieu D Ythier R Binet C Brambilla E Brambilla S Sengupta R Pedeux 2009 Ing2 controls the progression of DNA replication forks to maintain genome stability EMBO Rep 10 1168 1174 10.1038/embor.2009.180 19730436 1:CAS:528:DC%2BD1MXhtVygsbbF
8. I Garkavtsev IA Grigorian VS Ossovskaya MV Chernov PM Chumakov AV Gudkov 1998 The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control Nature 391 295 298 10.1038/34675 9440695 1:CAS:528:DyaK1cXnsV2ktQ%3D%3D (Pubitemid 28099018)
9. M Takahashi N Seki T Ozaki M Kato T Kuno T Nakagawa K-i Watanabe K Miyazaki M Ohira S Hayashi M Hosoda H Tokita H Mizuguchi T Hayakawa S Todo A Nakagawara 2002 Identification of the p33ING1-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG Cancer Res 62 2203 2209 11956069 1:CAS:528: DC%2BD38Xjt1ejt7k%3D
10. N Shinoura Y Muramatsu M Nishimura Y Yoshida A Saito T Yokoyama T Furukawa A Horii M Hashimoto A Asai T Kirino H Hamada 1999 Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas Cancer Res 59 5521 5528 10554029 1:CAS:528:DyaK1MXnt1Gju7c%3D
11. H Shimada TL Liu T Ochiai T Shimizu Y Haupt H Hamada T Abe M Oka M Takiguchi T Hiwasa 2002 Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33ING1 in T.Tn human esophageal carcinoma cells Oncogene 21 1208 1216 10.1038/sj.onc.1205176 11850840 1:CAS:528:DC%2BD38XitFSjtrY%3D
12. M Nagashima M Shiseki RM Pedeux S Okamura M Kitahama-Shiseki K Miura J Yokota CC Harris 2003 A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis Oncogene 22 343 350 10.1038/sj.onc.1206115 12545155 1:CAS:528:DC%2BD3sXlsV2lsQ%3D%3D (Pubitemid 36194330)
13. KJ Cheung G Li 2002 p33ING1 enhances UVB-induced apoptosis in melanoma cells Exp Cell Res 279 291 298 10.1006/excr.2002.5610 12243754 1:CAS:528:DC%2BD38XmvV2qu74%3D (Pubitemid 35217557)
14. K-J Cheung Jr D Mitchell P Lin G Li 2001 The tumor suppressor candidate p33ING1 mediates repair of UV-damaged DNA Cancer Res 61 4974 4977 11431327 1:CAS:528:DC%2BD3MXltVeqtbo%3D
15. W-HW Kuo Y Wang RPC Wong EI Campos G Li 2007 The ING1b tumor suppressor facilitates nucleotide excision repair by promoting chromatin accessibility to XPA Exp Cell Res 313 1628 1638 10.1016/j.yexcr.2007.02.010 17379210 1:CAS:528:DC%2BD2sXksV2kur0%3D (Pubitemid 46589439)
16. Y Wang J Wang G Li 2006 Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis FEBS Lett 580 3787 3793 10.1016/j.febslet.2006.05.065 16782091 1:CAS:528:DC%2BD28Xms1ahtbw%3D (Pubitemid 43946862)
17. J Wang MY Chin G Li 2006 The novel tumor suppressor p33ING2 enhances nucleotide excision repair via inducement of histone H4 acetylation and chromatin relaxation Cancer Res 66 1906 1911 10.1158/0008-5472.CAN-05-3444 16488987 1:CAS:528:DC%2BD28XhsFamtbg%3D
18. Y Doyon C Cayrou M Ullah A-J Landry V Côté W Selleck WS Lane S Tan X-J Yang J Côté 2006 ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation Mol Cell 21 51 64 10.1016/j.molcel.2005.12.007 16387653 1:CAS:528:DC%2BD28Xptlelsw%3D%3D (Pubitemid 43017848)
19. R Loewith M Meijer SP Lees-Miller K Riabowol D Young 2000 Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities Mol Cell Biol 20 3807 3816 10.1128/MCB.20.11.3807-3816.2000 10805724 1:CAS:528:DC%2BD3cXjt1Cms7c%3D (Pubitemid 30314480)
20. C Menendez M Abad D Gomez-Cabello A Moreno I Palmero 2009 ING proteins in cellular senescence Curr Drug Targets 10 406 417 10.2174/138945009788185077 19442113 1:CAS:528:DC%2BD1MXmslansrs%3D
21. S Shah K Riabowol 2009 Signaling pathways of the ING proteins in apoptosis Curr Drug Targets 10 385 391 10.2174/138945009788185103 19442111 1:CAS:528:DC%2BD1MXmslansr0%3D
22. M Gunduz M Ouchida K Fukushima H Hanafusa T Etani S Nishioka K Nishizaki K Shimizu 2000 Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas Cancer Res 60 3143 3146 10866301 1:CAS:528:DC%2BD3cXktlyktb8%3D
23. H Ding D Yang FR Wu H Li K Feng SJ Zheng CR Ni GZ Yu 2003 P33(ING1) gene expression and mutation in stomach cancer tissues and precarcinomatous tissues Zhonghua Yi Xue Za Zhi 83 320 323 12812652 1:CAS:528:DC%2BD3sXmvVKhtL8%3D
24. L Chen JB Wei YC Zhou S Zhang JL Liang YF Cao ZJ Tang XL Zhang F Gao 2005 Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer World J Gastroenterol 11 6120 6124 16273637 1:CAS:528:DC%2BD28XhsVentLg%3D
25. G Nouman JJ Anderson KM Wood J Lunec AG Hall MM Reid B Angus 2002 Loss of nuclear expression of the p33ING1b inhibitor of growth protein in childhood acute lymphoblastic leukaemia J Clin Pathol 55 596 601 10.1136/jcp.55.8.596 12147653 1:STN:280:DC%2BD38vjt1yktw%3D%3D
26. G Nouman JJ Anderson S Crosier J Shrimankar J Lunec B Angus 2003 Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast J Clin Pathol 56 507 511 10.1136/jcp.56.7.507 12835295 1:STN:280:DC%2BD3szjtFOntQ%3D%3D (Pubitemid 36819421)
27. T Ohgi T Masaki S Nakai A Morishita S Yukimasa M Nagai Y Miyauchi T Funaki K Kurokohchi S Watanabe S Kuriyama 2002 Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity Scand J Gastroenterol 37 1440 1448 10.1080/003655202762671332 12523595 1:CAS:528:DC%2BD3sXht1Sit7Y%3D (Pubitemid 36051506)
28. E Oki Y Maehara E Tokunaga Y Kakeji K Sugimachi 1999 Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer Cancer Lett 147 157 162 10.1016/S0304-3835(99)00288-8 10660101 1:CAS:528:DyaK1MXns1agsL4%3D
29. G Tallen I Kaiser S Krabbe U Lass C Hartmann G Henze K Riabowol A von Deimling 2004 No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma Int J Cancer 109 476 479 10.1002/ijc.11715 14961591 1:CAS:528:DC%2BD2cXhvVOgtbk%3D (Pubitemid 38252781)
30. E Tokunaga Y Maehara E Oki K Kitamura Y Kakeji S Ohno K Sugimachi 2000 Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers Cancer Lett 152 15 22 10.1016/S0304-3835(99)00434-6 10754201 1:CAS:528:DC%2BD3cXit1Whu70%3D (Pubitemid 30169013)
31. Z Zhu Z Luo Y Li C Ni H Li M Zhu 2009 Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner Hepatology 49 504 512 10.1002/hep.22675 19085961 1:CAS:528:DC%2BD1MXivFWht74%3D
32. D Vieyra R Loewith M Scott P Bonnefin FM Boisvert P Cheema S Pastyryeva M Meijer RN Johnston DP Bazett-Jones S McMahon MD Cole D Young K Riabowol 2002 Human ING1 proteins differentially regulate histone acetylation J Biol Chem 277 29832 29839 10.1074/jbc.M200197200 12015309 1:CAS:528:DC%2BD38XmsVKiu7o%3D
33. M Scott P Bonnefin D Vieyra F-M Boisvert D Young DP Bazett-Jones K Riabowol 2001 UV-induced binding of ING1 to PCNA regulates the induction of apoptosis J Cell Sci 114 3455 3462 11682605 1:CAS:528:DC%2BD3MXotVSqtLw%3D
34. D Skowyra M Zeremski N Nezanov M Li Y Choi M Uesugi CA Hauser W Gu AV Gudkov J Qin 2001 Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex J Biol Chem 276 8734 8739 10.1074/jbc.M007664200 11118440 1:CAS:528:DC%2BD3MXisVCntr4%3D
35. M Zeremski JE Hill SSS Kwek IA Grigorian KV Gurova IV Garkavtsev L Diatchenko EV Koonin AV Gudkov 1999 Structure and regulation of the mouse ING1 gene J Biol Chem 274 32172 32181 10.1074/jbc.274.45.32172 10542254 1:CAS:528:DyaK1MXnt12jtLk%3D (Pubitemid 29522958)
36. T Toyama I Hirotaka P Watson H Muzik E Saettler A Magliocco L DiFrancesco P Forsyth I Garkavtsev S Kobayashi K Riabowol 1999 Suppression of ING1 expression in sporadic breast cancer Oncogene 18 5187 5193 10.1038/sj.onc. 1202905 10498868 1:CAS:528:DyaK1MXmsVyhurk%3D (Pubitemid 29460654)
37. I Ahmed S Kelly J Anderson B Angus C Challen J Lunec 2007 The predictive value of p53 and p33ING1b in patients with Dukes'C colorectal cancer Colorectal Dis 10 344 351 10.1111/j.1463-1318.2007.01317.x 17949449
38. G Nouman JJ Anderson ME Mathers N Leonard S Crosier J Lunec B Angus 2002 Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions Histopathology 40 360 366 10.1046/j.1365-2559.2002.01369.x 11943021 1:STN:280: DC%2BD383gvFGrsQ%3D%3D (Pubitemid 34595587)
39. J Zhang DW Wang QX Li ZL Zhu MW Wang DS Cui YH Yang YX Gu XF Sun 2008 Nuclear to cytoplasmic shift of p33ING1b protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables J Cancer Res Clin Oncol 134 421 426 10.1007/s00432-007-0305-y 17805569 1:CAS:528:DC%2BD1cXhtFertLw%3D (Pubitemid 351170065)
40. W Gong M Russell K Suzuki K Riabowol 2006 Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression Mol Cell Biol 26 2947 2954 10.1128/MCB.26.8.2947-2954.2006 16581770 1:CAS:528:DC%2BD28Xjs1Slsbk%3D
41. K Cheung G Li 2002 The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells Int J Oncol 21 1361 1365 12429989 1:CAS:528:DC%2BD38XpsVygu78%3D
42. MY Chin KCP Ng G Li 2005 The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells Exp Cell Res 304 531 543 10.1016/j.yexcr.2004.11.023 15748897 1:CAS:528:DC%2BD2MXhvVCktrY%3D (Pubitemid 40321129)
43. M Nagashima M Shiseki K Miura K Hagiwara SP Linke R Pedeux XW Wang J Yokota K Riabowol CC Harris 2001 DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53 Proc Natl Acad Sci USA 98 9671 9676 10.1073/pnas.161151798 11481424 1:CAS:528:DC%2BD3MXmtlCnu7s%3D (Pubitemid 32769361)
44. M Unoki K Kumamoto AI Robles JC Shen Z-M Zheng CC Harris 2008 A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis FEBS Lett 582 3868 3874 10.1016/j.febslet.2008.10.024 18951897 1:CAS:528:DC%2BD1cXhsVSgs7rK
45. Ythier D, Brambilla E, Binet R, Nissou D, Vesin A, de Fraipont F, Moro-Sibilot D, Lantuejoul S, Brambilla C, Gazzeri S, Pedeux R (2009) Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma. Lung Cancer (in press)
46. K Kumamoto K Fujita R Kurotani M Saito M Unoki N Hagiwara H Shia ED Bowman N Yanaihara S Okamura M Nagashima K Miyamoto S Takenoshita J Yokota CC Harris 2009 ING2 is upregulated in colon cancer and increases invasion by enhanced mmp13 expression Int J Cancer 125 1306 1315 10.1002/ijc.24437 19437536 1:CAS:528:DC%2BD1MXovVelsb8%3D
47. S Borkosky M Gunduz H Nagatsuka LB Beder E Gunduz MAL Ali AP Rodriguez MZ Cilek S Tominaga N Yamanada K Shimizu N Nagai 2009 Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma J Cancer Res Clin Oncol 135 703 713 10.1007/s00432-008-0507-y 18998165 1:CAS:528:DC%2BD1MXjvVagtLk%3D
48. F Lu DL Dai M Martinka V Ho G Li 2006 Nuclear ING2 expression is reduced in human cutaneous melanomas Br J Cancer 95 80 86 10.1038/sj.bjc.6603205 16755297 1:CAS:528:DC%2BD28XmtFyrtLo%3D (Pubitemid 43980558)
49. T Okano A Gemma Y Hosoya Y Hosomi M Nara Y Kokubo A Yoshimura M Shibuya M Nagashima CC Harris S Kudoh 2006 Alterations in novel candidate tumor suppressor genes, ING1, and ING2 in human lung cancer Oncol Rep 15 545 549 16465410 1:CAS:528:DC%2BD28XitVWlsbc%3D
50. E Cetin B Cengiz E Gunduz M Gunduz H Nagatsuka LB Beder K Fukushima D Pehlivan M Ozaslan N Yamanada K Nishizaki K Shimizu N Nagai 2008 Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers Neoplasma 55 299 304 18505340 1:CAS:528:DC%2BD1cXovFOjt7Y%3D
51. E Sironi A Cerri D Tomasini SM Sirchia G Porta F Rossella FR Grati G Simoni 2004 Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes J Cutan Pathol 31 318 322 10.1111/j.0303-6987.2004.0187.x 15005689 (Pubitemid 38406745)
52. PV Peña F Davrazou X Shi KL Walter VV Verkhusha O Gozani R Zhao TG Kutateladze 2006 Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2 Nature 442 100 103 16728977
53. J Luo S Shah K Riabowol PE Mains 2009 The caenorhabditis elegans ING-3 gene regulates ionizing radiation-induced germ-cell apoptosis in a p53-associated pathway Genetics 181 473 482 10.1534/genetics.107.080515 19015549 1:CAS:528:DC%2BD1MXktVegsbY%3D
54. Y Wang G Li 2006 ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells J Biol Chem 281 11887 11893 10.1074/jbc.M511309200 16520380 1:CAS:528:DC%2BD28Xjslens74%3D (Pubitemid 43855450)
55. Y Wang DL Dai M Martinka G Li 2007 Prognostic significance of nuclear ING3 expression in human cutaneous melanoma Clin Cancer Res 13 4111 4116 10.1158/1078-0432.CCR-07-0408 17634537 1:CAS:528:DC%2BD2sXnvVCiu70%3D (Pubitemid 47105973)
56. Chen G, Wang Y, Garate M, Zhou J, Li G (2009) The tumor suppressor ING3 is degraded by SCFSkp2-mediated ubiquitin-proteasome system. Oncogene (in press)
57. Hung W-C, Tseng W-L, Shiea J, Chang H-C (2009) Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett (in press)
58. X Wang YP Wu B Ye DC Lin YB Feng ZQ Zhang X Xu YL Han Y Cai JT Dong QM Zhan M Wu MR Wang 2009 Suppression of anoikis by Skp2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma Mol Cancer Res 7 12 22 10.1158/1541-7786.MCR-08-0092 19147533 1:CAS:528: DC%2BD1MXltV2ltQ%3D%3D
59. Q Liao D Zhong Q Chen 2008 Protein expression of Skp2 in osteosarcoma and its relation with prognosis Zhong Nan Da Xue Xue Bao Yi Xue Ban 33 606 611 10.3736/jcim20080612 18667774 1:CAS:528:DC%2BD1MXlt1yktLY%3D (Pubitemid 351895369)
60. F-M Fang C-Y Chien C-F Li W-Y Shiu C-H Chen H-Y Huang 2009 Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients Int J Rad Oncol Biol Phys 73 202 207 1:CAS:528:DC%2BD1cXhsFajsrbF
61. J Zhao CL Yang SY Zhao 2007 Expression of Skp2 protein in lung carcinoma and its implication for prognosis Zhonghua Zhong Liu Za Zhi 29 289 292 17760257 1:CAS:528:DC%2BD1cXmvFGqtQ%3D%3D
62. T Einama Y Kagata H Tsuda D Morita S Ogata S Ueda T Takigawa N Kawarabayashi K Fukatsu Y Sugiura O Matsubara K Hatsuse 2006 High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome Pancreas 32 376 381 10.1097/01.mpa.0000220862.78248.c4 16670630 1:CAS:528:DC%2BD28XlsFCqs7w%3D (Pubitemid 43772193)
63. L Sui Y Dong Y Watanabe F Yamaguchi K Sugimoto M Tokuda 2006 Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors Oncol Rep 15 765 771 16525656 1:CAS:528: DC%2BD28Xjs1Kis7c%3D
64. K Harada K Supriatno S Kawaguchi Y Kawashima Y Itashiki H Yoshida M Sato 2005 High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation Anticancer Res 25 2471 2475 16080478 1:CAS:528:DC%2BD2MXoslGqsb4%3D
65. Y Kamata J Watanabe Y Nishimura T Arai M Kawaguchi M Hattori A Obokata H Kuramoto 2005 High expression of Skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma J Cancer Res Clin Oncol 131 591 596 10.1007/s00432-005-0671-2 16080017 1:CAS:528:DC%2BD2MXhtFGlt7bI (Pubitemid 41558552)
66. H Li X Jiang X Zhou 2005 Expression of Skp2 and p27 proteins in laryngeal squamous cell carcinoma and their significance Lin Chuang Er Bi Yan Hou Ke Za Zhi 19 409 411 16075976
67. W-Q Zheng J-M Zheng R Ma F-F Meng C-R Ni 2005 Relationship between levels of Skp2 and p27 in breast carcinomas and possible role of Skp2 as targeted therapy Steroids 70 770 774 10.1016/j.steroids.2005.04.012 16024059 1:CAS:528:DC%2BD2MXosVClur4%3D (Pubitemid 41169911)
68. I Takanami 2005 The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer Oncol Rep 13 727 731 15756449 1:CAS:528: DC%2BD2MXjtFansbw%3D
69. S Yokoi K Yasui M Mori T Iizasa T Fujisawa J Inazawa 2004 Amplification and overexpression of Skp2 are associated with metastasis of non-small-cell lung cancers to lymph nodes Am J Pathol 165 175 180 15215173 1:CAS:528: DC%2BD2cXmtFygtr4%3D
70. J Li T Masaki A Kubo J Fujita DA Dixon RD Beauchamp T Ishida S Kuriyama K Imaida 2004 Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors Int J Oncol 25 87 95 15201993
71. Y Dong L Sui Y Watanabe K Sugimoto M Tokuda 2003 S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications Oncol Rep 10 321 325 12579266 1:CAS:528: DC%2BD3sXhvFGks7o%3D
72. M Gunduz LB Beder E Gunduz H Nagatsuka K Fukushima D Pahlivan E Cetin N Yamanaka K Nishizaki K Shimizu N Nagai 2008 Downregulation of ING3 mRNA expression predicts poor prognosis in head and neck cancer Cancer Sci 99 531 538 10.1111/j.1349-7006.2007.00708.x 18081876 1:CAS:528:DC%2BD1cXjt1ehs70%3D (Pubitemid 351228570)
73. M Gunduz M Ouchida K Fukushima S Ito Y Jitsumori T Nakashima N Nagai K Nishizaki K Shimizu 2002 Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31 in human head and neck cancers Oncogene 21 4462 4470 10.1038/sj.onc.1205540 12080476 1:CAS:528:DC%2BD38XkslKntL8%3D (Pubitemid 34774848)
74. M Li Y Jin W-j Sun Y Yu J Bai D-d Tong J-p Qi J-r Du J-s Geng Q Huang X-y Huang Y Huang F-f Han X-n Meng JL Rosales K-Y Lee S-b Fu 2009 Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma J Pathol 219 87 95 10.1002/path.2571 19479822 1:CAS:528:DC%2BD1MXhtFGgs7zM
75. X Li L Cai H Chen Q Zhang S Zhang Y Wang Y Dong H Cheng J Qi 2009 Inhibitor of growth 4 induces growth suppression and apoptosis in glioma U87MG Pathobiology 76 181 192 10.1159/000218334 19571607 1:CAS:528: DC%2BD1MXnvF2rtbc%3D
76. J Li M Martinka G Li 2008 Role of ING4 in human melanoma cell migration, invasion and patient survival Carcinogenesis 29 1373 1379 10.1093/carcin/bgn086 18375955 1:CAS:528:DC%2BD1cXpslarsL4%3D
77. L Cai X Li S Zheng Y Wang Y Wang H Li J Yang J Sun 2009 Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14 Melanoma Res 19 1 7 10.1097/CMR. 0b013e32831bc42f 19430401 1:CAS:528:DC%2BD1MXjtlOkurw%3D
78. M Gunduz H Nagatsuka K Demircan E Gunduz B Cengiz M Ouchida H Tsujigiwa E Yamachika K Fukushima L Beder S Hirohata Y Ninomiya K Nishizaki K Shimizu N Nagai 2005 Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas Gene 356 109 117 10.1016/j.gene.2005.02.014 15935570 1:CAS:528:DC%2BD2MXot1Wmtbc%3D (Pubitemid 41175976)
79. Y Xie H Zhang W Shen J Xiang Z Ye J Yang 2008 Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis Cancer Lett 271 105 116 10.1016/j.canlet.2008.05.050 18789575 1:CAS:528:DC%2BD1cXht1Sis7nO
80. X Li L Cai M Liang Y Wang J Yang Y Zhao 2008 ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/beta-Catenin signaling pathway Anatomical Rec 291 593 600 10.1002/ar.20685 1:CAS:528:DC%2BD1cXmt1CmtLk%3D (Pubitemid 351644535)
81. X Zhang L-S Xu Z-Q Wang K-S Wang N Li Z-H Cheng S-Z Huang D-Z Wei Z-G Han 2004 ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells FEBS Lett 570 7 12 10.1016/j.febslet.2004.06. 010 15251430 1:CAS:528:DC%2BD2cXls1eitLs%3D (Pubitemid 38900947)
82. F Fang LB Luo YM Tao F Wu LY Yang 2009 Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma Cancer Epidemiol Biomarkers Prev 18 409 416 10.1158/1055-9965.EPI-08-0575 19208663 1:CAS:528:DC%2BD1MXhslShtbs%3D
83. S Kim K Chin JW Gray JM Bishop 2004 A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer Proc Natl Acad Sci USA 101 16251 16256 10.1073/pnas. 0407158101 15528276 1:CAS:528:DC%2BD2cXhtVWks7nN (Pubitemid 39552831)
84. S Kim 2005 HuntING4 new tumor suppressors Cell Cycle 4 516 517 15738650 1:CAS:528:DC%2BD28XhslCqtL0%3D
85. T Hung O Binda KS Champagne AJ Kuo K Johnson HY Chang MD Simon TG Kutateladze O Gozani 2009 ING4 mediates crosstalk between histone H3K4 trimethylation and H3 acetylation to attenuate cellular transformation Mol Cell 33 248 256 10.1016/j.molcel.2008.12.016 19187765 1:CAS:528:DC%2BD1MXhvVyltrw%3D
86. A Ozer RK Bruik 2005 Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4 Cell Cycle 4 1153 1156 16096374 1:CAS:528:DC%2BD28XktVCgt7g%3D
87. A Ozer LC Wu RK Bruick 2005 The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF) Proc Natl Acad Sci USA 102 7481 7486 10.1073/pnas.0502716102 15897452 1:CAS:528:DC%2BD2MXkslOnt7c%3D (Pubitemid 40740997)
88. S Colla S Tagliaferri F Morandi P Lunghi G Donofrio D Martorana C Mancini M Lazzaretti L Mazzera L Ravanetti S Bonomini L Ferrari C Miranda M Ladetto TM Neri A Neri A Greco M Mangoni A Bonati V Rizzoli N Guiliani 2007 The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1 alpha) activity: involvement in myeloma-induced angiogenesis Blood 110 4464 4475 10.1182/blood-2007-02-074617 17848618 1:CAS:528:DC%2BD1cXot1Wk (Pubitemid 351377813)
89. I Garkavtsev SV Kozin O Chernova L Xu F Winkler E Brown GH Barnett RK Jain 2004 The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis Nature 428 328 332 10.1038/nature02329 15029197 1:CAS:528:DC%2BD2cXitFCntbg%3D (Pubitemid 38418804)
90. S Nozell T Laver D Moseley L Nowoslawski M DeVos GP Atkinson K Harrison LB Nabors EN Benveniste 2008 The ING4 tumor suppressor attenuates NF-κB activity at the promoters of target genes Mol Cell Biol 28 6632 6645 10.1128/MCB.00697-08 18779315 1:CAS:528:DC%2BD1cXhtlWiu7bL
91. G Gadea M deToledo C Anguille P Roux 2007 Loss of p53 promotes Rhoa-ROCK-dependent cell migration and invasion in 3D matrices J Cell Biol 178 23 30 10.1083/jcb.200701120 17606864 1:CAS:528:DC%2BD2sXnsVajurw%3D (Pubitemid 47026399)
92. K Gao DL Dai M Martinka G Li 2006 Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration Cancer Res 66 8382 8388 10.1158/0008-5472.CAN-05-4402 16951147 1:CAS:528: DC%2BD28XovF2isr8%3D (Pubitemid 44449148)
93. M Shiseki M Nagashima RM Pedeux M Kitahama-Shiseki K Miura S Okamura H Onogi Y Higashimoto E Appella J Yokota CC Harris 2003 P29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity Cancer Res 63 2373 2378 12750254 1:CAS:528:DC%2BD3sXjslehsrg%3D
94. B Cengiz M Gunduz H Nagatsuka L Beder E Gunduz R Tamamura N Mahmut K Fukushima MAS Ali Y Naomoto K Shimizu N Nagai 2007 Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer Oral Oncol 43 241 247 10.1016/j.oraloncology.2006.03.004 16857411 1:CAS:528:DC%2BD2sXhvVyrsrc%3D (Pubitemid 46228008)
95. J Shen M Unoki D Ythier A Duperray L Varticovski K Kumamoto R Pedeux CC Harris 2007 Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with novel binding partner, liprin alpha 1 Cancer Res 67 2552 2558 10.1158/0008-5472.CAN-06-3870 17363573 1:CAS:528:DC%2BD2sXivV2nsr8%3D (Pubitemid 46548940)
96. M Unoki JC Shen ZM Zheng CC Harris 2006 Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility J Biol Chem 281 34677 34686 10.1074/jbc.M606296200 16973615 1:CAS:528:DC%2BD28XhtFKgur3I (Pubitemid 46036673)